GlassScriptPhysician profile
Raj Ballal
NPI 1386645638
$26,032.70
in general payments reported to CMS, 2019-2025
42 companies · $3,987 in 2025
The $3,987 reported for 2025 was more than what 90% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,704 · 2020: $1,177 · 2021: $5,569 · 2022: $5,001 · 2023: $2,767 · 2024: $5,827 · 2025: $3,987.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Travel and Lodging: $293 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,219.68 |
| Travel and Lodging | $293.00 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,496.10 | 2019-2025 | Coroflow, Xience Skypoint, Cardiomems |
| Astrazeneca Pharmaceuticals LP | $3,000.79 | 2019-2025 | Lokelma, Farxiga, Fasenra |
| Medtronic, INC. | $1,776.07 | 2021-2025 | Symplicity G3, Onyx Frontier, Ffrangio |
| Abiomed | $1,653.36 | 2022-2025 | Impella |
| Boston Scientific Corporation | $1,642.52 | 2019-2025 | Guidezilla, Watchman, Synergy |
| Impulse Dynamics (USA) INC. | $1,622.37 | 2021-2024 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,108.27 | 2020-2024 | Jardiance |
| Biotronik INC. | $1,079.83 | 2019-2025 | Biomonitor, Amvia Edge, Acticor 7 Vr-T Dx |
| Cvrx, INC. | $917.34 | 2021-2025 | Barostim Neo System |
| Shockwave Medical, INC | $896.17 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Janssen Pharmaceuticals, INC | $894.57 | 2019-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $867.36 | 2021-2025 | Camzyos, Eliquis |
| Novartis Pharmaceuticals Corporation | $728.50 | 2019-2025 | |
| Novo Nordisk INC | $536.71 | 2022-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $499.91 | 2021-2025 | Arexvy |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $448.29 | 2019-2022 | |
| Amgen INC. | $401.20 | 2020-2023 | Repatha |
| Medtronic Vascular, INC. | $377.35 | 2019-2020 | |
| Scpharmaceuticals INC. | $359.76 | 2024-2025 | |
| Vital Connect, INC | $310.61 | 2024-2025 | Vitalpatch Rtm |
| Inari Medical, INC. | $272.52 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Viiv Healthcare Company | $249.89 | 2022-2024 | Cabenuva |
| Heartflow, INC. | $244.93 | 2024-2025 | |
| Penumbra, INC. | $220.45 | 2021-2025 | Indigo System |
| Kowa Pharmaceuticals America, INC. | $164.13 | 2021-2022 | |
| Edwards Lifesciences Corporation | $157.40 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $151.12 | 2019-2025 | Lifevest |
| Philips North America LLC | $148.94 | 2022 | |
| Lexicon Pharmaceuticals, INC. | $143.31 | 2023-2024 | Inpefa |
| Phathom Pharmaceuticals, INC. | $121.33 | 2025 | Voquezna |
| Zoll Respicardia, INC. | $118.72 | 2023 | Remede System |
| Astellas Pharma US INC | $100.42 | 2019 | |
| Terumo Medical Corporation | $97.86 | 2019-2021 | |
| Cardiovascular Systems INC. | $58.11 | 2022 | |
| Imperative Care, INC | $47.64 | 2025 | Symphony Catheter |
| Atricure, INC. | $24.36 | 2025 | Atriclip Laa Exclusion System |
| Bayer Healthcare Pharmaceuticals INC. | $18.80 | 2025 | |
| Angiodynamics, INC. | $17.27 | 2024 | Alphavac |
| Daiichi Sankyo INC. | $15.79 | 2023 | Injectafer |
| Merck Sharp & Dohme LLC | $15.00 | 2023 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $14.99 | 2024 | Arcalyst |
| Pfizer INC. | $12.64 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raj Ballal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.